Steven A Curley1, Flavio Palalon, Xiaolin Lu, Nadezhda V Koshkina. 1. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Mechanical Engineering and Materials Science, Rice University, Houston, Texas.
Abstract
BACKGROUND: The development of novel therapeutic approaches for cancer therapy is important, especially for tumors that have poor response or develop resistance to standard chemotherapy and radiation. We discovered that noninvasive radiofrequency (RF) fields can affect cancer cells but not normal cells, inhibit progression of tumors in mice, and enhance the anticancer effects of chemotherapy. However, it remains unclear what physiological and molecular mechanisms this treatment induces inside cells. Here, we studied the effect of RF treatment on mitochondria in human pancreatic cancer cells. METHODS: The morphology of mitochondria in cells was studied via electron microscopy. The alteration of mitochondrial membrane potential (Δψ) was accessed using a Mitotracker probe. The respiratory activity of mitochondria was evaluated by analyzing changes in oxygen consumption rates determined with a Mito Stress Test Kit. The production of intracellular reactive oxygen species was performed using flow cytometry. The colocalization of mitochondria and autophagosome markers in cells was performed using fluorescence immunostaining and confocal microscopy analysis. RESULTS: RF fields treatment changed the morphology of mitochondria in cancer cells, altered polarization of the mitochondrial membrane, substantially impaired mitochondrial respiration, and increased reactive oxygen species production, indicating RF-induced stress on the mitochondria. We also observed frequent colocalization of the autophagosome marker LC3B with the mitochondrial marker Tom20 inside cancer cells after RF exposure, indicating the presence of mitochondria in the autophagosomes. This suggests that RF-induced stress can damage mitochondria and induce elimination of damaged organelles via autophagy. CONCLUSION: RF treatment impaired the function of mitochondria in cancer cells. Therefore, mitochondria can represent one of the targets of the RF treatment.
BACKGROUND: The development of novel therapeutic approaches for cancer therapy is important, especially for tumors that have poor response or develop resistance to standard chemotherapy and radiation. We discovered that noninvasive radiofrequency (RF) fields can affect cancer cells but not normal cells, inhibit progression of tumors in mice, and enhance the anticancer effects of chemotherapy. However, it remains unclear what physiological and molecular mechanisms this treatment induces inside cells. Here, we studied the effect of RF treatment on mitochondria in humanpancreatic cancer cells. METHODS: The morphology of mitochondria in cells was studied via electron microscopy. The alteration of mitochondrial membrane potential (Δψ) was accessed using a Mitotracker probe. The respiratory activity of mitochondria was evaluated by analyzing changes in oxygen consumption rates determined with a Mito Stress Test Kit. The production of intracellular reactive oxygen species was performed using flow cytometry. The colocalization of mitochondria and autophagosome markers in cells was performed using fluorescence immunostaining and confocal microscopy analysis. RESULTS:RF fields treatment changed the morphology of mitochondria in cancer cells, altered polarization of the mitochondrial membrane, substantially impaired mitochondrial respiration, and increased reactive oxygen species production, indicating RF-induced stress on the mitochondria. We also observed frequent colocalization of the autophagosome marker LC3B with the mitochondrial marker Tom20 inside cancer cells after RF exposure, indicating the presence of mitochondria in the autophagosomes. This suggests that RF-induced stress can damage mitochondria and induce elimination of damaged organelles via autophagy. CONCLUSION:RF treatment impaired the function of mitochondria in cancer cells. Therefore, mitochondria can represent one of the targets of the RF treatment.
Authors: Eleanor R Adair; Dennis W Blick; Stewart J Allen; Kevin S Mylacraine; John M Ziriax; Dennis M Scholl Journal: Bioelectromagnetics Date: 2005-09 Impact factor: 2.010
Authors: Mustafa Raoof; Brandon T Cisneros; Stuart J Corr; Flavio Palalon; Steven A Curley; Nadezhda V Koshkina Journal: PLoS One Date: 2013-07-04 Impact factor: 3.240
Authors: H Petra Kok; Erik N K Cressman; Wim Ceelen; Christopher L Brace; Robert Ivkov; Holger Grüll; Gail Ter Haar; Peter Wust; Johannes Crezee Journal: Int J Hyperthermia Date: 2020 Impact factor: 3.914
Authors: Matthew J Ware; Louis T Curtis; Min Wu; Jason C Ho; Stuart J Corr; Steven A Curley; Biana Godin; Hermann B Frieboes Journal: Sci Rep Date: 2017-06-13 Impact factor: 4.379
Authors: Steven A Curley; Flavio Palalon; Kelly E Sanders; Nadezhda V Koshkina Journal: Int J Environ Res Public Health Date: 2014-09-03 Impact factor: 3.390
Authors: Jian-Shu Lou; Wen-Chuan Bi; Gallant K L Chan; Yan Jin; Chau-Wing Wong; Zhong-Yu Zhou; Huai-You Wang; Ping Yao; Tina T X Dong; Karl W K Tsim Journal: Oncotarget Date: 2017-10-16